-
2
-
-
0035282590
-
Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996
-
Rosenstein NE, Emery KW, Werner SB, et al: Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001; 32: 708-15.
-
(2001)
Clin Infect Dis
, vol.32
, pp. 708-715
-
-
Rosenstein, N.E.1
Emery, K.W.2
Werner, S.B.3
-
3
-
-
0031945858
-
Risk factors for primary pulmonary coccidioidomycosis hospitalizations among United States Navy and Marine Corps personnel, 1981-1994
-
Gray GC, Fogle EF, Albright KL: Risk factors for primary pulmonary coccidioidomycosis hospitalizations among United States Navy and Marine Corps personnel, 1981-1994. Am J Trop Med Hyg 1998; 28: 309-12.
-
(1998)
Am J Trop Med Hyg
, vol.28
, pp. 309-312
-
-
Gray, G.C.1
Fogle, E.F.2
Albright, K.L.3
-
4
-
-
0021868108
-
Erythrocyte sedimentation rate: From folklore to facts
-
Bedell SE, Bush BT: Erythrocyte sedimentation rate: from folklore to facts. Am J Med 1985; 78: 1001-9.
-
(1985)
Am J Med
, vol.78
, pp. 1001-1009
-
-
Bedell, S.E.1
Bush, B.T.2
-
5
-
-
0024100438
-
Symptoms and routine laboratory abnormalities associated with coccidioidomycosis
-
Yozwiak ML, Lundergan LL, Kerrick SS, Galgiani JN: Symptoms and routine laboratory abnormalities associated with coccidioidomycosis. West J Med 1988; 149: 419-21.
-
(1988)
West J Med
, vol.149
, pp. 419-421
-
-
Yozwiak, M.L.1
Lundergan, L.L.2
Kerrick, S.S.3
Galgiani, J.N.4
-
6
-
-
0031038175
-
Detection of antibodies to Coccidioides immitis by enzyme immunoassay
-
Zartarian M, Peterson EM, de la Maza LM: Detection of antibodies to Coccidioides immitis by enzyme immunoassay. Am J Clin Pathol 1997; 107: 148-53.
-
(1997)
Am J Clin Pathol
, vol.107
, pp. 148-153
-
-
Zartarian, M.1
Peterson, E.M.2
De La Maza, L.M.3
-
7
-
-
0030731081
-
Prediction of relapse after treatment of coccidioidomycosis
-
Oldfield III EC, Bone WD, Martin CR, Gray GC, Olson P, Schillaci RF: Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis 1997; 25: 1205-10.
-
(1997)
Clin Infect Dis
, vol.25
, pp. 1205-1210
-
-
Oldfield III, E.C.1
Bone, W.D.2
Martin, C.R.3
Gray, G.C.4
Olson, P.5
Schillaci, R.F.6
-
8
-
-
0033796766
-
Practice guidelines for the treatment of coccidioidomycosis
-
Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL: Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis 2000; 30: 658-61.
-
(2000)
Clin Infect Dis
, vol.30
, pp. 658-661
-
-
Galgiani, J.N.1
Ampel, N.M.2
Catanzaro, A.3
Johnson, R.H.4
Stevens, D.A.5
Williams, P.L.6
-
9
-
-
0034619472
-
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis
-
Galgiani JN, Catanzaro A, Cloud GA, et al: Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. Ann Intern Med 2000; 133: 676-86.
-
(2000)
Ann Intern Med
, vol.133
, pp. 676-686
-
-
Galgiani, J.N.1
Catanzaro, A.2
Cloud, G.A.3
-
10
-
-
84907125033
-
Efficacy of AmBisome in murine coccidioidomycosis
-
Albert MM, Adams K, Luther MJ, Sun SH, Graybill JR: Efficacy of AmBisome in murine coccidioidomycosis. J Med Vet Myc 1994; 32: 467-71.
-
(1994)
J Med Vet Myc
, vol.32
, pp. 467-471
-
-
Albert, M.M.1
Adams, K.2
Luther, M.J.3
Sun, S.H.4
Graybill, J.R.5
-
11
-
-
0029148287
-
Amphotericin B nephrotoxicity: The adverse consequences of altered membrane properties
-
Sawaya BP, Briggs JP, Schnermann J: Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol 1995; 6: 154-64.
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 154-164
-
-
Sawaya, B.P.1
Briggs, J.P.2
Schnermann, J.3
-
12
-
-
0025830941
-
Effect of salt supplementation on amphotericin B nephrotoxicity
-
Llanos, A. Cieza, J. Bernardo, J, et al: Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int 1991; 40: 302-8.
-
(1991)
Kidney Int
, vol.40
, pp. 302-308
-
-
Llanos, A.1
Cieza, J.2
Bernardo, J.3
|